Aug. 19, 2016 – The Affordable Care Act (ACA) has resulted in increases in the use of prescription drugs and decreases in out-of-pocket spending, according to the RAND Corporation, which conducted a study of how expanded insurance coverage has affected populations that are at risk for high health spending. Health Affairs, which described the results […]
Read moreNov. 9, 2015 – Congress, federal agencies and the media continue to turn up the heat on their examination of drug pricing practices, but the industry is starting to defend itself – with facts. As part of a multi-pronged effort to defend the worth of pharmaceutical companies and their products, the Pharmaceutical Research and Manufacturers […]
Read moreOct. 30, 2015 – The drug industry may have additional work to do to improve the public’s perception of its advertising, according to Kaiser Health Tracking Poll findings reported Oct. 28. Although a high percentage of the public (82 percent) reports having seen or heard a prescription drug direct-to-consumer (DTC) ad, only 51 percent of […]
Read moreOct. 26, 2015 – There is no question that prescription drugs have a cost to patients and payers, but that cost is more than offset by the value those drugs provide, according to several speakers at a session of the Coalition for Healthcare Communication (CHC) meeting held Oct. 21 in Washington, D.C. Key action steps […]
Read more